VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The promise of targeted combination therapies in CLL & their impact on immune function

Clare Sun, MD, National Institutes of Health, Bethesda, MD, shares her excitement for clinical trials evaluating targeted therapy combinations in chronic lymphocytic leukemia (CLL), highlighting the importance of investigating the impact these therapies may have on the immune system. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research funding: Genmab

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter